Immunogenicity of Biopharmaceuticals - 6 Angebote vergleichen
| Preise | 2013 | 2014 | 2018 | 2019 |
|---|---|---|---|---|
| Schnitt | € 102,39 | € 201,75 | € 142,73 | € 190,39 |
| Nachfrage |
1
Immunogenicity of Biopharmaceuticals (Biotechnology: Pharmaceutical Aspects) (2008)
EN NW FE EB DLISBN: 9780387758411 bzw. 0387758410, in Englisch, 267 Seiten, Springer, neu, Erstausgabe, E-Book, elektronischer Download.
Lieferung aus: Deutschland, E-Book zum Download.
A particular issue for biopharmaceuticals that has not been addressed comprehensively in any book, is the potential of an immune response to the biopharmaceutical product. That is, the human body marks the drug as a foreign body, and develops antibodies against the drug. These antibodies may be relatively harmless, but may also cross-react with the endogenous compound, causing autoimmunogenicity. Recent adverse experiences in Europe with Janssen-Ortho s blockbuster product Eprex has increased the attention towards potential immunogenicity of biopharmaceuticals, above all from the regulatory agencies. This book is intended to give a broad overview of the current state-of-the-art regarding the immune response to biopharmaceuticals. The chapters range from an overview of the immune system and factors that may trigger the immune system, via detection of antibodies and clinical implications, to various case examples and the regulatory view on immunogenicity. , Kindle Edition, Ausgabe: 1, Format: Kindle eBook, Label: Springer, Springer, Produktgruppe: eBooks, Publiziert: 2008-03-21, Freigegeben: 2008-03-21, Studio: Springer.
A particular issue for biopharmaceuticals that has not been addressed comprehensively in any book, is the potential of an immune response to the biopharmaceutical product. That is, the human body marks the drug as a foreign body, and develops antibodies against the drug. These antibodies may be relatively harmless, but may also cross-react with the endogenous compound, causing autoimmunogenicity. Recent adverse experiences in Europe with Janssen-Ortho s blockbuster product Eprex has increased the attention towards potential immunogenicity of biopharmaceuticals, above all from the regulatory agencies. This book is intended to give a broad overview of the current state-of-the-art regarding the immune response to biopharmaceuticals. The chapters range from an overview of the immune system and factors that may trigger the immune system, via detection of antibodies and clinical implications, to various case examples and the regulatory view on immunogenicity. , Kindle Edition, Ausgabe: 1, Format: Kindle eBook, Label: Springer, Springer, Produktgruppe: eBooks, Publiziert: 2008-03-21, Freigegeben: 2008-03-21, Studio: Springer.
2
Immunogenicity of Biopharmaceuticals (2008)
~EN NW EBISBN: 9780387758411 bzw. 0387758410, vermutlich in Englisch, Springer, neu, E-Book.
Lieferung aus: Deutschland, Sofort per Download lieferbar.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
3
Immunogenicity of Biopharmaceuticals
EN NW EBISBN: 9780387758411 bzw. 0387758410, in Englisch, Springer Nature, neu, E-Book.
Lieferung aus: Vereinigtes Königreich Großbritannien und Nordirland, In Stock.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Lade…